FORTUNE: Inside Pfizer's palace coup
Found via My Investing Notebook.
Did CEO Jeff Kindler get pushed out because he was shaking up the dysfunctional pharmaceutical giant -- or because he's an ineffective leader?
For Jeff Kindler, it was a humiliating moment. The CEO of Pfizer, the world's largest pharmaceutical company, had been summoned to the airport in Fort Myers, Fla., on Saturday, Dec. 4, 2010, for a highly unusual purpose: to plead for his job.
Three stone-faced directors, representing the company's board, sat inside a drab airport conference room as the CEO, trained as a trial lawyer, struggled to argue his most important case. Alerted to this meeting less than 24 hours earlier, Kindler detailed his accomplishments, speaking nonstop for the better part of an hour. He touted his bold reorganizations, praised his administration's sweeping cost reductions, and rhapsodized about his reinvention of Pfizer's crucial research-and-development operations.
But the three board members, Constance Horner, a former deputy secretary at the U.S. Department of Health and Human Services; George Lorch, an ex-CEO of Armstrong World Holdings; and Bill Gray, a former Philadelphia congressman, weren't there to debate the direction of the company. The board had spent a frantic week in an urgent investigation: A revolt had erupted against Kindler among a handful of senior managers, and the directors were trying to figure out what was going on. One possibility: an internal power grab. Another: a CEO who was unraveling.
- Under The Umbrella I Found Integrity
I was on the phone with my friend from Philadelphia while sitting on my deck in Brentwood (not too far from the former home of Heisman Trophy winning USC tailback Orenthal J. Simpson) enjoying a glass of Walter Hansel 2006 chardonnay from the Russian...
- The Financial Zoo: An Interview With Satyajit Das – Part I
Via the Naked Capitalism blog: SD: It’s amazing how much money you can make just shuffling paper backwards and forwards. Malcolm Gladwell wrote a piece praising John Paulson who made a killing from the subprime disaster as an entrepreneur. But what...
- Dividend Increase - Kinder Morgan, Inc. (kmi)
Yesterday, the Board of Directors for Kinder Morgan, Inc (KMI) announced an increase in the quarterly dividend from $0.36 to $0.37 per share. The new rate will be payable on February 15th to shareholders of record as of January 31st. The increase...
- Recent Buy - Glaxosmithkline (gsk)
Wow the markets have been taking a beating here lately and there's some stocks out there looking pretty cheap. The market volatility coupled with some troubling company headwinds are hitting some stocks extra hard. GSK is certainly not immune to such...
- Recent Dividend Increases
Dividend investors would be wise to focus not just on a stock's current yield, but also on the long-term growth potential of its dividends. That's because strong businesses that consistently raise their dividend payouts reward shareholders with...